Literature DB >> 12552564

Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.

Arleen D Auerbach1, Jason Greenbaum, Kanan Pujara, Sat Dev Batish, Marco A Bitencourt, Indira Kokemohr, Hildegard Schneider, Stephan Lobitzc, Ricardo Pasquini, Philip F Giampietro, Helmut Hanenberg, Orna Levran.   

Abstract

Fanconi anemia (FA) is a genetically heterogeneous autosomal recessive syndrome associated with chromosomal instability, hypersensitivity to DNA cross-linking agents, and predisposition to malignancy. The gene for FA complementation group G (FANCG) was the third FA gene to be cloned, and was found to be identical with human XRCC9, which maps to 9p13. The cDNA is predicted to encode a polypeptide of 622 amino acids, with no sequence similarities to any other known protein or motifs that could point to a molecular function for FANCG/XRCC9. We used single strand conformational polymorphism analysis (SSCP) to screen genomic DNA from a panel of 307 racially and ethnically diverse unrelated FA patients from the International Fanconi Anemia Registry (IFAR) for variants in FANCG. Twenty-seven abnormal SSCP patterns were found; 18 of these variants appear to be pathogenic mutations while nine are likely to be nonpathogenic polymorphisms. Direct sequencing of genomic DNA from seven FA-G probands with one mutant allele not detected in the SSCP study and three additional probands assigned to the FA-G complementation group by retroviral correction with FANCG resulted in the detection of nine additional pathogenic mutations and two common SNPs. Conditions for rapid screening for these mutations by DHPLC for use in a clinical laboratory setting were established. The most common FANCG mutations in the IFAR population were: IVS8-2A>G (seven Portuguese-Brazilian probands), IVS11+1G>C (seven French-Acadian probands), 1794_1803del10 (seven European probands), and IVS3+1G>C (five Korean or Japanese probands). Our data suggest that the Portuguese-Brazilian, French-Acadian, and Korean/Japanese mutations were likely to have been present in a founding member of each of these populations. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552564     DOI: 10.1002/humu.10166

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.

Authors:  Elizabeth K Flynn; Aparna Kamat; Francis P Lach; Frank X Donovan; Danielle C Kimble; Narisu Narisu; Erica Sanborn; Farid Boulad; Stella M Davies; Alfred P Gillio; Richard E Harris; Margaret L MacMillan; John E Wagner; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

Review 2.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

3.  Diagnosis of Fanconi anemia by diepoxybutane analysis.

Authors:  Arleen D Auerbach
Journal:  Curr Protoc Hum Genet       Date:  2015-04-01

4.  Loss of Mitochondrial Localization of Human FANCG Causes Defective FANCJ Helicase.

Authors:  Jagadeesh Chandra Bose K; Bishwajit Singh Kapoor; Kamal Mandal; Shubhrima Ghosh; Raveendra B Mokhamatam; Sunil K Manna; Sudit S Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2020-11-06       Impact factor: 4.272

Review 5.  Current insights into inherited bone marrow failure syndromes.

Authors:  Nack-Gyun Chung; Myungshin Kim
Journal:  Korean J Pediatr       Date:  2014-08-25

6.  Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing.

Authors:  Johan J P Gille; Karijn Floor; Lianne Kerkhoven; Najim Ameziane; Hans Joenje; Johan P de Winter
Journal:  Anemia       Date:  2012-06-21

7.  A founder variant in the South Asian population leads to a high prevalence of FANCL Fanconi anemia cases in India.

Authors:  Frank X Donovan; Avani Solanki; Minako Mori; Niranjan Chavan; Merin George; Selvaa Kumar C; Yusuke Okuno; Hideki Muramastsu; Kenichi Yoshida; Akira Shimamoto; Akifumi Takaori-Kondo; Hiromasa Yabe; Seishi Ogawa; Seiji Kojima; Miharu Yabe; Ramanagouda Ramanagoudr-Bhojappa; Agata Smogorzewska; Sheila Mohan; Aruna Rajendran; Arleen D Auerbach; Minoru Takata; Settara C Chandrasekharappa; Babu Rao Vundinti
Journal:  Hum Mutat       Date:  2019-09-26       Impact factor: 4.700

8.  A strategy for molecular diagnostics of Fanconi anemia in Brazilian patients.

Authors:  Daniela V Pilonetto; Noemi F Pereira; Carmem M S Bonfim; Lisandro L Ribeiro; Marco A Bitencourt; Lianne Kerkhoven; Karijn Floor; Najim Ameziane; Hans Joenje; Johan J P Gille; Ricardo Pasquini
Journal:  Mol Genet Genomic Med       Date:  2017-05-09       Impact factor: 2.183

9.  Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG.

Authors:  Pedro Reyes; Benilde García-de Teresa; Ulises Juárez; Fernando Pérez-Villatoro; Moisés O Fiesco-Roa; Alfredo Rodríguez; Bertha Molina; María Teresa Villarreal-Molina; Jorge Meléndez-Zajgla; Alessandra Carnevale; Leda Torres; Sara Frias
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.